本產品只用于科研，不用于診斷，也不屬于醫療用品

特異性: This antibody preparation contains a mixture of purified rat monoclonal antibodies  directed

against mouse GPIba (CD42b). Targeting of this receptor with divalent IgGs results in profound and

irreversible Fc-independent plaet depletion in mice^1,2. Plaet depletion is frequently used to study

the general role of plaets in (patho-) physiology³.

制備 : 抗體是雜交瘤細胞上清通過G-Sepharose純化所得，內毒素含量小于 0.0025 EU/µg

保存和運輸：4度保存和運輸，保質期為6個月 ，無菌保存不含防腐劑，分裝保存-20度至少可以保存一年以上，但請避免反復凍融

使用方法: 按動物體重注射抗體，用 量為2 µg抗體/g動物體重，可以參見上圖。如果4 µg抗體/g動物體重，可以持續更長時間。注射后60分鐘內可以去除血小板95%以上，建議每次注射100-200µL抗體（用無菌PBS稀釋）。詳情聯系靶點科技技術支持。可以聯合清除巨噬細胞（LIPOSOMA，CP-005-005）和中性粒細胞，咨詢綜合解決方案。

引用文獻:

1. Bergmeier W, Rackebrandt K, Schroder W, Zirngibl H, Nieswandt B. (2000) Structural and functional characterization of the mouse von Willebrand

factor receptor GPIb-IX with novel monoclonal antibodies. Blood. 95:886-93.

2. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, and Zirngibl H. (2000) Identification of critical antigen-specific mechanisms in the

development of immune thrombocytopenic purpura in mice. Blood. 96:2520-27.

3. Elzey BD, Tian J, Jensen RJ et al. (2003) Plaet-mediated modulation of adaptive immunity. A communication link between innate and adaptive

immune compartments. Immunity.19:9-19.